Nami Ohashi

1.4k total citations
64 papers, 1.1k citations indexed

About

Nami Ohashi is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Nami Ohashi has authored 64 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 20 papers in Infectious Diseases and 19 papers in Virology. Recurrent topics in Nami Ohashi's work include HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (19 papers) and Chemical Synthesis and Analysis (14 papers). Nami Ohashi is often cited by papers focused on HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (19 papers) and Chemical Synthesis and Analysis (14 papers). Nami Ohashi collaborates with scholars based in Japan, United States and Singapore. Nami Ohashi's co-authors include Hirokazu Tamamura, A. S. Pine, Wataru Nomura, Tetsuo Narumi, Kazuhisa Yoshimura, Shigeyoshi Harada, Shuzo Matsushita, Jon T. Hougen, Chie Hashimoto and Naoki Yamamoto and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and The Journal of Chemical Physics.

In The Last Decade

Nami Ohashi

63 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nami Ohashi Japan 19 442 328 305 280 276 64 1.1k
Srinivas Odde United States 17 336 0.8× 135 0.4× 165 0.5× 90 0.3× 189 0.7× 24 980
Rama K. Kondru United States 16 298 0.7× 125 0.4× 83 0.3× 394 1.4× 188 0.7× 24 978
S. K. Burt United States 17 442 1.0× 317 1.0× 327 1.1× 173 0.6× 358 1.3× 28 1.4k
John P. Marino United States 30 2.0k 4.5× 183 0.6× 134 0.4× 423 1.5× 75 0.3× 98 2.6k
S. Maignan France 12 786 1.8× 164 0.5× 184 0.6× 44 0.2× 42 0.2× 13 1.2k
Chong‐Hwan Chang United States 28 1.8k 4.0× 564 1.7× 700 2.3× 122 0.4× 301 1.1× 51 3.0k
Miriam Gochin United States 24 806 1.8× 329 1.0× 293 1.0× 363 1.3× 73 0.3× 57 1.5k
Paul R. Blake United States 15 680 1.5× 279 0.9× 193 0.6× 150 0.5× 69 0.3× 21 1.2k
Georgios Archontis Cyprus 26 1.6k 3.6× 40 0.1× 50 0.2× 176 0.6× 468 1.7× 53 2.3k
Frederick S. Lee United States 10 854 1.9× 53 0.2× 66 0.2× 150 0.5× 337 1.2× 11 1.7k

Countries citing papers authored by Nami Ohashi

Since Specialization
Citations

This map shows the geographic impact of Nami Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nami Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nami Ohashi more than expected).

Fields of papers citing papers by Nami Ohashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nami Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nami Ohashi. The network helps show where Nami Ohashi may publish in the future.

Co-authorship network of co-authors of Nami Ohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Nami Ohashi. A scholar is included among the top collaborators of Nami Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nami Ohashi. Nami Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ishii, Takahiro, Takuya Kobayakawa, Kouki Matsuda, et al.. (2023). Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity. European Journal of Medicinal Chemistry. 256. 115449–115449. 8 indexed citations
3.
Kobayakawa, Takuya, Masaru Yokoyama, Kohei Tsuji, et al.. (2023). Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins. RSC Advances. 13(3). 2156–2167. 5 indexed citations
4.
Kobayakawa, Takuya, Kohei Tsuji, Masayuki Fujino, et al.. (2020). Bivalent HIV-1 fusion inhibitors based on peptidomimetics. Bioorganic & Medicinal Chemistry. 28(24). 115812–115812. 2 indexed citations
5.
Kojima, Hiroyuki, Yuki Fujita, Ryosuke Takeuchi, et al.. (2020). Cyclization Reaction-Based Turn-on Probe for Covalent Labeling of Target Proteins. Cell chemical biology. 27(3). 334–349.e11. 23 indexed citations
6.
Kobayakawa, Takuya, K Konno, Nami Ohashi, et al.. (2019). Soluble-type small-molecule CD4 mimics as HIV entry inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(5). 719–723. 18 indexed citations
7.
Kobayakawa, Takuya, Nami Ohashi, Yuki Hirota, et al.. (2018). Flexibility of small molecular CD4 mimics as HIV entry inhibitors. Bioorganic & Medicinal Chemistry. 26(21). 5664–5671. 10 indexed citations
8.
Ohashi, Nami, et al.. (2016). Evidence that ubiquitylated H2B corrals hDot1L on the nucleosomal surface to induce H3K79 methylation. Nature Communications. 7(1). 10589–10589. 60 indexed citations
9.
Harada, Shigeyoshi, Tomoyuki Miura, Nami Ohashi, et al.. (2015). A minimally cytotoxic CD4 mimic as an HIV entry inhibitor. Bioorganic & Medicinal Chemistry Letters. 26(2). 397–400. 23 indexed citations
10.
Hashimoto, Chie, Tetsuo Narumi, Yuki Hirota, et al.. (2013). A CD4 mimic as an HIV entry inhibitor: Pharmacokinetics. Bioorganic & Medicinal Chemistry. 21(24). 7884–7889. 18 indexed citations
11.
Narumi, Tetsuo, Hiroshi Arai, Kazuhisa Yoshimura, et al.. (2013). CD4 mimics as HIV entry inhibitors: Lead optimization studies of the aromatic substituents. Bioorganic & Medicinal Chemistry. 21(9). 2518–2526. 32 indexed citations
12.
Nomura, Wataru, Chie Hashimoto, Nami Ohashi, et al.. (2013). Multimerized CHR-derived peptides as HIV-1 fusion inhibitors. Bioorganic & Medicinal Chemistry. 21(15). 4452–4458. 22 indexed citations
13.
Narumi, Tetsuo, Haruo Aikawa, Tomohiro Tanaka, et al.. (2012). Low‐Molecular‐Weight CXCR4 Ligands with Variable Spacers. ChemMedChem. 8(1). 118–124. 7 indexed citations
14.
Tanaka, Tomohiro, Tetsuo Narumi, Nami Ohashi, et al.. (2011). Azamacrocyclic Metal Complexes as CXCR4 Antagonists. ChemMedChem. 6(5). 834–839. 25 indexed citations
15.
Narumi, Tetsuo, Kazuhisa Yoshimura, Shigeyoshi Harada, et al.. (2010). CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist. Bioorganic & Medicinal Chemistry Letters. 20(19). 5853–5858. 37 indexed citations
16.
Suzuki, Shintaro, Kasthuraiah Maddali, Chie Hashimoto, et al.. (2010). Peptidic HIV integrase inhibitors derived from HIV gene products: Structure–activity relationship studies. Bioorganic & Medicinal Chemistry. 18(18). 6771–6775. 17 indexed citations
17.
18.
Tamamura, Hirokazu, Tomohiro Tanaka, Hiroshi Tsutsumi, et al.. (2009). Development of Chemokine Receptor CXCR4 Antagonists Using Bio-mimetic Strategy. Advances in experimental medicine and biology. 611. 145–146. 2 indexed citations
19.
Ohashi, Nami, Wataru Nomura, Mai Kato, et al.. (2009). Synthesis of protein kinase Cδ C1b domain by native chemical ligation methodology and characterization of its folding and ligand binding. Journal of Peptide Science. 15(10). 642–646. 9 indexed citations
20.
Tanaka, Tomohiro, Hiroshi Tsutsumi, Wataru Nomura, et al.. (2008). Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore. Organic & Biomolecular Chemistry. 6(23). 4374–4374. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Srinivas Odde Breakdown of academic impact, for papers by Rama K. Kondru Breakdown of academic impact, for papers by S. K. Burt Breakdown of academic impact, for papers by John P. Marino Breakdown of academic impact, for papers by S. Maignan Breakdown of academic impact, for papers by Chong‐Hwan Chang Breakdown of academic impact, for papers by Miriam Gochin Breakdown of academic impact, for papers by Paul R. Blake Breakdown of academic impact, for papers by Georgios Archontis Breakdown of academic impact, for papers by Frederick S. Lee
Rankless by CCL
2026